Sat, Mar 7, 2015, 12:22 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. (SNTA) Message Board

  • amiretiredyet1 amiretiredyet1 Oct 22, 2012 9:53 AM Flag

    Yoo Hoo Mr. Market

    SNTA’s only about to extend the life of 75% of second line adeno lung cancer patients from 7 to around 18 months! Annual sales projected to top $2 billion. (Slide 7 of Oct presentation.) That’s all.

    That’s all with 2nd line non-small cell lung cancer that is.

    Wait till they get to 1st line non-small lung cancer, breast, prostate, ovarian, head&neck, gastric & bladder cancer. Not to mention their monotherapy trials.

    I predict that this undiscovered diamond in the rough won’t stay the way for long.

2.53-0.14(-5.24%)Mar 6 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.